• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Oxeia Initiates Trial for OXE103 for Concussions americanpharmaceuticalreview
    October 28, 2020
    Oxeia Biopharmaceuticals announced the initiation of a Phase 2 clinical trial of OXE103 for treating concussion. The Phase 2 clinical study is being conducted by Dr. Michael Rippee, an assistant professor of neurology at the ...

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service